The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference59 articles.
1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018
2. A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade;Thommen;Nat. Med.,2018
3. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden;Hellmann;N. Engl. J. Med.,2018
4. Pembrolizumab versus Chemotherapy for PD-L1-Positive non-small-Cell Lung Cancer;Reck;N. Engl. J. Med.,2016
5. Tumor and microenvironment evolution during immunotherapy with nivolumab;Riaz;Cell,2017
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer;OncoImmunology;2024-02-06
2. CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion;BMC Immunology;2023-12-12
3. Function-associated scRNA-seq on single lung cancer organoids unravels the immune landscape of tumor parenchyma;2023-12-12
4. The effect of immune cell traits on efficacy and adverse drug reactions of platinum drugs: A Mendelian randomization analysis;2023-11-11
5. CD39 deletion in TCR-engineered T cells enhances antitumour immunity;Gut;2023-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3